Fluticasone Furoate Suppliers & Bulk Manufacturers
Available Forms: Nasal Spray
Available Strengths: 27.5 mcg
Reference Brands: Veramyst®(US), Avamys®(EU)
Category:
Allergy Medication
Fluticasone Furoate is a corticosteroid used for allergic rhinitis and asthma. Available as a nasal spray (27.5 mcg) and inhalation powder (100/200 mcg). Key brands include Avamys®, Veramyst®, and Breo Ellipta® (with vilanterol).
Fluticasone Furoate is available in Nasal Spray
and strengths such as 27.5 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluticasone Furoate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluticasone Furoate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluticasone Furoate is a potent intranasal and inhaled corticosteroid used for managing allergic rhinitis and asthma. Available in nasal spray and inhalation forms, it reduces inflammation and offers once-daily dosing for long-term relief. Key brands include Avamys® (EU), Veramyst® (US), and Breo Ellipta® (with vilanterol for asthma/COPD). Common strengths: 27.5 mcg/spray (nasal), 100 mcg, and 200 mcg (inhalation). Manufactured in GMP-compliant facilities, Fluticasone Furoate is ideal for hospital supply, private labeling, and bulk B2B distribution in regulated markets across the EU and US.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing